Atransferrinemia is an extremely rare inherited disorder in which the blood carries almost no transferrin, the protein that moves iron from one part of the body to another. Without it, iron cannot reach the immature red blood cells in the bone marrow, so affected people develop a severe anemia in which the red cells are small and pale. At the same time the gut absorbs far more iron than the body needs, and the surplus settles in organs such as the liver, heart, joints, pancreas, kidneys and thyroid. Over time this iron overload can scar the liver, bring on arthritis and an underactive thyroid, and weaken the heart. Children often show slow growth and repeated infections. The condition is caused by changes in the TF gene on chromosome 3 and is passed on as an autosomal recessive trait, so it appears when a child inherits a faulty copy from each parent. A milder form, called hypotransferrinemia, comes from changes in the same gene. Fewer than a dozen families have been reported in the medical literature, and the condition was first described in 1961. Treatment has relied on infusions of plasma or purified transferrin, together with supportive care.
Facts
Classification
Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) First Described Connections
Treated By
Source Atransferrinemia (NORD Rare Disease Database)
Sources
1. Atransferrinemia (NORD Rare Disease Database)
Affected populations
Atransferrinemia was first described in the medical literature in 1961.
Disease overview
Atransferrinemia is principally caused by mutations of the transferrin ( TF ) gene and is inherited as an autosomal recessive trait.
Disease overview [disease-category]
Atransferrinemia is an extremely rare genetic disorder
Causes
It is inherited as an autosomal recessive trait.
Disease overview, blood disorder with heart involvement
Atransferrinemia is an extremely rare genetic disorder characterized by low levels of healthy, functional red cells in the blood (hypochromic, microcytic anemia) and by the accumulation of excess iron in the body (hemosiderosis).
Treated By: Fresh Frozen Plasma Transfusion, Standard therapies, treatment
Affected individuals have been treated with infusions of plasma or of a urified form of transferrin (apotransferrin) that may correct certain symptoms (e.g., anemia, growth deficiencies) associated with the disorder.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.